Form 4 Filing for Contineum Therapeutics, Inc. - Ignelzi Troy A. Stock Option Grant

This filing details a stock option grant to Ignelzi Troy A., a director at Contineum Therapeutics, Inc. The grant, consisting of 19,000 stock options for Class A Common Stock, was made under the Issuer's 2024 Equity Incentive Plan as part of the Non-Employee Director Compensation Program. The options have an exercise price of $14.19 per share and will vest in full on June 26, 2027, or the next annual stockholder meeting, provided continuous service is maintained. The transaction date was June 26, 2026, with an expiration date of June 25, 2036. The filing was made by Peter Slover as Attorney-in-Fact.